The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A three-arm randomized phase II study of dostarlimab alone or with bevacizumab versus nonplatinum chemotherapy in recurrent gynecological clear cell carcinoma: DOVE (APGOT-OV7/ENGOT-ov80 study).
 
Jung-Yun Lee
Consulting or Advisory Role - AstraZeneca; MSD; Roche; Takeda
Research Funding - Ascendis Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Janssen Oncology (Inst); Merck (Inst); Mersana (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); OncoQuest Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst); Takeda (Inst)
 
David Shao Peng Tan
Stock and Other Ownership Interests - Asian Microbiome Library
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Eisai; Genmab; GlaxoSmithKline; MSD; Roche
Speakers' Bureau - AstraZeneca; Eisai; GlaxoSmithKline; Merck Serono; MSD; Roche; Takeda
Research Funding - AstraZeneca; Bayer; BerGenBio; Byondis; Karyopharm Therapeutics; Roche; Zeria Pharmaceutical
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Daiichi Sankyo; DECIPHERA; Genmab; GlaxoSmithKline; IMMUNOCORE; Immunogen; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; PMV Pharma; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; Blueprint Medicines; BMS; Bristol-Myers Squibb; Clovis Oncology; Daichi; Deciphera; Eisai; Genmab; GlaxoSmithKline; Immunocore; Immunogen; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Ose pharma; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES
 
Jung Bok Lee
No Relationships to Disclose
 
Byoung-Gie Kim
No Relationships to Disclose
 
Els Van Nieuwenhuysen
Consulting or Advisory Role - AstraZeneca (Inst); Oncoinvent; Regeneron (Inst)
Research Funding - AstraZeneca (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oncoinvent (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Regeneron (Inst)
 
Ruby Yun-Ju Huang
Employment - ACT Genomics (I); Ferring (I)
Leadership - ACT Biotech (I)
Stock and Other Ownership Interests - ACT genomics (I)
Honoraria - Astrazeneca
Consulting or Advisory Role - Roche (I)
Travel, Accommodations, Expenses - AstraZeneca
 
Ka Yu Tse
No Relationships to Disclose
 
Antonio Gonzalez Martin
Consulting or Advisory Role - Alkermes; Amgen; AstraZeneca; Clovis Oncology; Genmab; Hedera Dx; Immunogen; Kartos Therapeutics; Macrogenics; Mersana; MSD; Novartis; Novocure; Oncoinvent; Pfizer/EMD Serono; Roche; Seagen; SOTIO; Sutro Biopharma; Takeda; Tesaro/GSK; Tubulis GmbH
Speakers' Bureau - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro/GSK
Research Funding - Roche (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; PharmaMar; Roche; Tesaro/GSK
 
Clare L. Scott
Consulting or Advisory Role - Oncology One
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Eisai; IDEAYA Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - Royalty agreement for venetoclax (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Illumina; MSD
(OPTIONAL) Uncompensated Relationships - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Kosei Hasegawa
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Genmab; Kyowa Kirin; MSD K.K; Sanofi; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Genmab; Kaken Pharmaceutical; MSD K.K; Roche; Sanofi; Takeda
Research Funding - Daiichi Sankyo; Merck; Ono Pharmaceutical
 
Katie Wilkinson
No Relationships to Disclose
 
Eunyeong Yang
Research Funding - BeiGene; BerGenBio; GI inovation; Merck
 
Rebecca Kristeleit
Honoraria - AstraZeneca; Basilea Pharmaceutical; Celcuity; Clovis Oncology; GlaxoSmithKline; Incyte; Leucid Bio; Merck Sharp & Dohme; Regeneron; Roche/Genentech; Shattuck Labs; Tesaro
Consulting or Advisory Role - Basilea; Cerulean Pharma; Clovis Oncology; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; MSD Oncology